ToolsConductScience tool
Biotech / PharmaFree in-browser calculator

GLP Audit Checklist.

Generate an ALCOA+ data integrity checklist for GLP studies with 21 CFR Part 58 requirements mapped to your study scope and records.

PrivateData stays in your browser
LiveNo sign-up required
Open methodFormula shown on this page
CitableMethods and citation included

Calculator

Results update in place

Try it out

Load example GLP audit checklist data to see the full workflow

Study Information

Audit Scope

Records to Audit

|
Required fields
  • Select at least one record category to audit.
  • Audit period start date must be YYYY-MM-DD format.
  • Audit period end date must be YYYY-MM-DD format.
  • Study title is required.
  • Study director name is required.
  • Facility name is required.

When to use

  • Pre-study QA readiness assessment
  • In-life phase audit preparation
  • End-of-study data integrity review before report issuance
  • Periodic GLP facility self-inspection

Do not use for

  • Non-GLP exploratory or discovery studies
  • Clinical trial data integrity (use ICH E6 GCP checklist)
  • Manufacturing GMP compliance (use 21 CFR Part 211)

Pearl

Run the checklist BEFORE study initiation to identify gaps in SOPs, training, and systems. Fixing data integrity issues mid-study is far more costly than preventing them.

Pearl

Enable audit trails on ALL electronic systems that generate GLP data — including spreadsheets. A standalone Excel file without version control is an audit finding waiting to happen.

Pitfall

Do not assume "electronic = compliant." An electronic system without validated audit trail, access controls, and backup procedures may be worse than paper from a data integrity perspective.

Pitfall

Corrections that obscure the original entry (white-out, overwriting, deleting electronic records) are among the most common FDA 483 observations. Always preserve the original and document the reason for change.

1

Method

The checklist generator applies all nine ALCOA+ principles as universal checks, then filters 21 CFR Part 58 requirements to the specific record categories selected. Requirements are mapped to CFR sections (§58.29 through §58.195) so each check item is traceable to its regulatory source. The gap analysis template includes the most common FDA 483 observations related to data integrity in GLP studies.

2

Published

Published 2026-04-08. Calculations support planning and documentation; verify procurement decisions against manufacturer specifications or institutional SOPs.

3

How to cite

How to Cite

ConductScience GLP Audit Trail & Data Integrity Checklist. ConductScience. https://conductscience.com/tools/glp-audit-checklist

21 CFR Part 58 — Good Laboratory Practice for Nonclinical Laboratory Studies. U.S. FDA.

MHRA "GxP" Data Integrity Guidance and Definitions (2018).

Understanding ALCOA+ Data Integrity for GLP Studies

Data integrity is the foundation of GLP compliance. Regulatory agencies worldwide use the ALCOA+ framework to evaluate whether study data is trustworthy:

Attributable: Every data point must identify who generated it, when, and on what system. Electronic audit trails must capture user ID and timestamp for every action.
Legible: Data must be readable throughout its retention period. Handwritten data in permanent ink; electronic data in accessible formats. Corrections use single-line strikethrough — the original must remain readable.
Contemporaneous: Data recorded at the time of the activity. FDA inspectors compare instrument timestamps against study schedules to detect backdating.
Original: First recording or a certified true copy. "Transcribing" from unofficial notes to official forms is a common audit finding.
Accurate: Verified calculations, calibrated instruments, and consistent units. Selective reporting (cherry-picking favorable data) is a critical finding.
Complete, Consistent, Enduring, Available (the + in ALCOA+): No deleted data without justification, no contradictions between related records, durable storage media, and accessible archives.

The most common FDA 483 observations related to data integrity involve: missing audit trails on electronic systems, inadequate correction practices, and failure to retain original data.

Frequently asked

What is ALCOA+ and why does it matter for GLP?
ALCOA+ stands for Attributable, Legible, Contemporaneous, Original, Accurate — plus Complete, Consistent, Enduring, and Available. These principles define data integrity standards required by FDA, EMA, and MHRA for regulated studies. GLP inspectors evaluate data against these criteria.
What records does 21 CFR Part 58 require?
21 CFR Part 58 (FDA GLP regulations) requires documentation for: study protocols, raw data, final reports, test article characterization, equipment calibration, personnel qualifications, QA inspections, and archive management. The specific sections (§58.29 through §58.195) define requirements for each area.
Do hybrid GLP-research studies need the full checklist?
Hybrid studies where only certain phases are conducted under GLP should apply the full GLP checklist to the regulated portions. Non-GLP phases should still follow good documentation practices but are not subject to 21 CFR Part 58 inspection. Use the "in-life" or "analytical" scope to generate a targeted checklist.
How often should GLP audit inspections be conducted?
Per §58.35, QA inspections must be at intervals "adequate to assure the integrity of the study." For most studies, this means at least: protocol review before study start, critical phase inspections (e.g., first dose, interim sacrifice), process inspections during data collection, and final report review before issuance.
325
Free tools
1,200+
Institutions
100%
Client-side
0
Uploads required